Ising, M., N. Höhne, A. Siebertz, A. M. Parchmann, A. Erhardt and M. Keck: Stress Response Regulation in Panic Disorder. In: Current Pharmaceutical Design 18, 35, 5675-5684 (2012).
Reif, A., H. Weber, K. Domschke, B. Klauke, C. Baumann, C. P. Jacob, A. Ströhle, A. L. Gerlach, G. W. Alpers, P. Pauli, A. Hamm, T. Kircher, V. Arolt, H. U. Wittchen, E. B. Binder, A. Erhardt and J. Deckert: Meta-analysis argues for a female-specific role of MAOA-uVNTR in panic disorder in four European populations. In: American Journal of Medical Genetics Part B-Neuropsychiatric Genetics 159B, 7, 786-793 (2012).
Domschke, K., A. Reif, H. Weber, J. Richter, C. Hohoff, P. Ohrmann, A. Pedersen, J. Bauer, T. Suslow, H. Kugel, W. Heindel, C. Baumann, B. Klauke, C. Jacob, W. Maier, J. Fritze, B. Bandelow, P. Krakowitzky, M. Rothermundt, A. Erhardt, E. B. Binder, F. Holsboer, A. L. Gerlach, T. Kircher, T. Lang, G. W. Alpers, A. Ströhle, L. Fehm, A. T. Gloster, H. U. Wittchen, V. Arolt, P. Pauli, A. Hamm and J. Deckert: Neuropeptide S receptor gene-converging evidence for a role in panic disorder. In: Molecular Psychiatry 16, 9, 938-948 (2011).
Buttenschøn, H. N., A. S. Kristensen, H. N. Buch, J. H. Andersen, J. P. Bonde, M. Grynderup, A. M. Hansen, H. Kolstad, A. Kaergaard, L. Kaerlev, S. Mikkelsen, J. F. Thomsen, P. Koefoed, A. Erhardt, D. P. D. Woldbye, A. D. Børglum and O. Mors: The norepinephrine transporter gene is a candidate gene for panic disorder. In: Journal of Neural Transmission 118, 6, 969-976 (2011).
Erhardt, A., L. Czibere, D. Roeske, S. Lucae, P. G. Unschuld, S. Ripke, M. Specht, M. A. Kohli, S. Kloiber, M. Ising, A. Heck, H. Pfister, P. Zimmermann, R. Lieb, B. Pütz, M. Uhr, P. Weber, J. M. Deussing, M. Gonik, M. Bunck, M. S. Kessler, E. Frank, C. Hohoff, K. Domschke, P. Krakowitzky, W. Maier, B. Bandelow, C. Jacob, J. Deckert, S. Schreiber, J. Strohmaier, M. Nöthen, S. Cichon, M. Rietschel, T. Bettecken, M. E. Keck, R. Landgraf, B. Müller-Myhsok, F. Holsboer and E. B. Binder: TMEM132D, a new candidate for anxiety phenotypes: evidence from human and mouse studies. In: Molecular Psychiatry 16, 6, 647-663 (2011).
Quast, C., A. Altmann, P. Weber, M. Rex-Haffner, A. Erhardt, B. Müller-Myhsok and E. B. Binder: Screening for rare variants in TMEM132D: a candidate gene from genome-wide association studies in anxiety disorders. In: European Neuropsychopharmacology 21, Suppl. 1, S6-S7 (2011).
Hohoff, C., E. L. Mullings, S. V. Heatherley, C. M. Freitag, L. C. Neumann, K. Domschke, P. Krakowitzky, M. Rothermundt, M. E. Keck, A. Erhardt, P. G. Unschuld, C. Jacob, J. Fritze, B. Bandelow, W. Maier, F. Holsboer, P. J. Rogers and J. Deckert: Adenosine A(2A) receptor gene: Evidence for association of risk variants with panic disorder and anxious personality. In: Journal of Psychiatric Research 44, 14, 930-937 (2010).
Ditzen, C., J. Varadarajulu, L. Czibere, M. Gonik, B. S. Targosz, B. Hambsch, T. Bettecken, M. S. Kessler, E. Frank, M. Bunck, L. Teplytska, A. Erhardt, F. Holsboer, B. Mueller-Myhsok, R. Landgraf and C. W. Turck: Proteomic-based genotyping in a mouse model of trait anxiety exposes disease-relevant pathways. In: Molecular Psychiatry 15, 7, 702-711 (2010).
Unschuld, P. G., M. Ising, D. Roeske, A. Erhardt, M. Specht, S. Kloiber, M. Uhr, B. Müller-Myhsok, F. Holsboer and E. B. Binder: Gender-Specific Association of Galanin Polymorphisms with HPA-Axis Dysregulation, Symptom Severity, and Antidepressant Treatment Response. In: Neuropsychopharmacology 35, 7, 1583-1592 (2010).
Thoeringer, C. K., A. Erhardt, I. Sillaber, M. B. Mueller, F. Ohl, F. Holsboer and M. E. Keck: Long-term anxiolytic and antidepressant-like behavioural effects of tiagabine, a selective GABA transporter-1 (GAT-1) inhibitor, coincide with a decrease in HPA system activity in C57BL/6 mice. In: Journal of Psychopharmacology 24, 5, 733-743 (2010).
http://edoc.mpg.de
The Max Planck Society does not take any responsibility for the content of this export.